[Chemical Constituents from Goodyera schlechtendaliana].

OBJECTIVE: To study the chemical constituents of Goodyera schlechtendaliana. METHODS: Compounds were isolated through various chromatographic techniques and identified by spectroscopic analysis and comparison with those in literature. RESULTS: Seven compounds were obtained from 95% ethanol extract. Their structures were identified as syringaldehyde (I), 5-hydroxymethylfurfural (II) , alloimperatorin (III), vanillic acid (IV), ferulic acid (V), glyceroyl monopalmitate (VI) and ß-sitosterol (VII). CONCLUSION: Compounds II- VII are reported from this genus and compounds I - VII are reported from this plant for the first time.

Growth differentiation factor 15 predicts cardiovascular events in stable coronary artery disease.

BACKGROUND: Growth differentiation factor 15 (GDF-15) has been explored as a potential biomarker for various inflammatory diseases and cardiovascular events. This study aimed to assess the predictive role of GDF-15 levels in cardiovascular events and all-cause mortality, considering traditional risk factors and other biomarkers. METHODS: A prospective study was conducted and 3699 patients with stable coronary artery disease (CAD) were enrolled into the research. Baseline GDF-15 levels were measured. Median follow-up was 3.1 years during the study. We analyzed clinical variables and several biomarkers. Multivariable Cox regression analysis was performed to evaluate prognostic performance of GDF-15 levels in predicting myocardial infarction (MI), heart failure, stroke, cardiovascular death, and non-cardiovascular death. RESULTS: Baseline GDF-15 levels for 3699 patients were grouped by quartile (≤ 1153, 1153-1888, 1888-3043, > 3043 ng/L). Higher GDF-15 levels were associated with older age, male gender, history of hypertension, and elevated levels of N-terminal pro B-type natriuretic peptide (NT-pro BNP), soluble suppression of tumorigenesis-2 (sST2), and creatine (each with P < 0.001). Adjusting for established risk factors and biomarkers in Cox proportional hazards models, a 1 standard deviation (SD) increase in GDF-15 was associated with elevated risk of clinical events [hazard ratio (HR) = 2.18, 95% confidence interval (CI): (1.52-3.11)], including: MI [HR = 2.83 95% CI: (1.03-7.74)], heart failure [HR = 2.71 95% CI: (1.18-6.23)], cardiovascular and non-cardiovascular death [HR = 2.48, 95% CI (1.49-4.11)] during the median follow up of 3.1 years. CONCLUSIONS: Higher levels of GDF-15 consistently provides prognostic information for cardiovascular events and all cause death, independent of clinical risk factors and other biomarkers. GDF-15 could be considered as a valuable addition to future risk prediction model in secondary prevention for predicting clinical events in patient with stable CAD.

Efficient fractionation of woody biomass hemicelluloses using cholinium amino acids-based deep eutectic solvents and their aqueous mixtures.

Novel and green cholinium amino acids-based deep eutectic solvents (DESs) and their aqueous mixtures were synthesized and employed in deconstructing poplar for hemicellulose fractionation. The effects of water content in DESs on hemicellulose dissociation and structural features were comprehensively investigated, along with the reusability of DESs for treatment. The integration of water into DESs could facilitate hemicellulose fractionation, and the cholinium lysine: urea with 5 wt% water (CL: U-5) demonstrated the best performance with a hemicellulose yield of 59.2%. Further structure analysis revealed that hemicelluloses with various branching degrees and molecular weights were obtained with varying water content of DESs. Furthermore, the CL: U-5 had recyclability and reusability with a 40.5% hemicellulose yield obtained after reused three times. The novel and eco-friendly cholinium amino acids-based DESs treatment provides an effective and sustainable strategy for hemicellulose fractionation from woody biomass.

Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma.

BACKGROUND: We aimed to validate the lymph node ratio (LNR) as an independent prognostic factor in oral squamous cell carcinoma (OSCC) and compare its utility with the current nodal staging system. METHODS: We conducted a retrospective analysis of 313 patients with OSCC undergoing neck dissection. The LNR was adjusted by relevant covariates in a multivariable Cox regression model. RESULTS: LNR displaced conventional nodal staging and was shown to be an independent predictor of regional failure (p = .020), disease-specific (p = .003) and overall survival (p = .001). Patients with an LNR of 2.5% to 7.5%, 7.5% to 20%, and >20% had 2.6, 3.7, and 4.4 times the risk of death from OSCC, respectively, when compared with patients with an LNR <2.5%. CONCLUSIONS: The LNR is an independent prognostic factor in OSCC and may be used in conjunction with the current TNM staging to enable better risk stratification and selection for adjuvant therapy.

Performance on the single-leg squat task indicates hip abductor muscle function.

BACKGROUND: Contemporary clinical expertise and emerging research in anterior knee pain indicate that treatment of hip muscle function will result in greater effects, if such treatments can be provided to those with hip muscle dysfunction. Thus, it is imperative to develop and evaluate a clinical assessment tool that is capable of identifying people with poor hip muscle function. HYPOTHESIS: The clinical assessment of single-leg squat performance will have acceptable inter- and intrarater reliability. Furthermore, people with good performance on the single-leg squat will have better hip muscle function (earlier onset of gluteus medius activity and greater lateral trunk, hip abduction, and external rotation strength) than people with poor performance. STUDY DESIGN: Cohort study (diagnosis); Level of evidence, 2. METHODS: A consensus panel of 5 experienced clinicians developed criteria to rate the performance of a single-leg squat task as "good," "fair," or "poor." The panel rated the performance of 34 asymptomatic participants (mean ± SD: age, 24 ± 5 y; height, 1.69 ± 0.10 m; weight, 65.0 ± 10.7 kg), and these ratings served as the standard. The ratings of 3 different clinicians were compared with those of the consensus panel ratings (interrater reliability) and to their own rating on 2 occasions (intrarater reliability). For the participants rated as good performers (n = 9) and poor performers (n = 12), hip muscle strength (hip abduction, external rotation, and trunk side bridge) and onset timing of anterior (AGM) and posterior gluteus medius (PGM) electromyographic activity were compared. RESULTS: Concurrency with the consensus panel was excellent to substantial for the 3 raters (agreement 87%-73%; κ = 0.800-0.600). Similarly, intrarater agreement was excellent to substantial (agreement 87%-73%; κ = 0.800-0.613). Participants rated as good performers had significantly earlier onset timing of AGM (mean difference, -152; 95% confidence interval [CI], -258 to -48 ms) and PGM (mean difference, -115; 95% CI, -227 to -3 ms) electromyographic activity than those who were rated as poor performers. The good performers also exhibited greater hip abduction torque (mean difference, 0.47; 95% CI, 0.10-0.83 N·m·Bw(-1)) and trunk side flexion force (mean difference, 1.08; 95% CI, 0.25-1.91 N·Bw(-1)). There was no difference in hip external rotation torque (P > .05) between the 2 groups. CONCLUSION: Targeted treatments, although considered ideal, rely on the capacity to identify subgroups of people with chronic anterior knee pain who might respond optimally to a given treatment component. Clinical assessment of performance on the single-leg squat task is a reliable tool that may be used to identify people with hip muscle dysfunction.